|
EXT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.186800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.744200E-01 |
| Normal-vs-Stage2 |
4.403800E-01 |
| Normal-vs-Stage3 |
4.469200E-01 |
| Normal-vs-Stage4 |
9.930200E-01 |
| Stage1-vs-Stage2 |
2.845000E-01 |
| Stage1-vs-Stage3 |
1.701650E-01 |
| Stage1-vs-Stage4 |
8.399400E-01 |
| Stage2-vs-Stage3 |
8.496600E-01 |
| Stage2-vs-Stage4 |
5.277600E-01 |
| Stage3-vs-Stage4 |
5.395600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.526600E-01 |
| Normal-vs-AfricanAmerican |
3.809400E-01 |
| Normal-vs-Asian |
7.981400E-01 |
| Caucasian-vs-AfricanAmerican |
3.558200E-01 |
| Caucasian-vs-Asian |
8.504800E-01 |
| AfricanAmerican-vs-Asian |
8.595200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.110800E-01 |
| Normal-vs-Female |
8.777800E-01 |
| Male-vs-Female |
9.403400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.550000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.748800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.998600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.234200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.832800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.770400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.400200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.886800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.951400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.291600E-02 |
| Normal-vs-Grade 2 |
9.877600E-01 |
| Normal-vs-Grade 3 |
3.634600E-01 |
| Normal-vs-Grade 4 |
6.126200E-01 |
| Grade 1-vs-Grade 2 |
8.382300E-03 |
| Grade 1-vs-Grade 3 |
4.781000E-03 |
| Grade 1-vs-Grade 4 |
1.909420E-01 |
| Grade 2-vs-Grade 3 |
1.954620E-01 |
| Grade 2-vs-Grade 4 |
5.752800E-01 |
| Grade 3-vs-Grade 4 |
2.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.768600E-01 |
| Normal-vs-ccB subtype |
6.444000E-01 |
| ccA subtype-vs-ccB subtype |
3.765800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.884400E-01 |
| Normal-vs-N1 |
2.328400E-01 |
| N0-vs-N1 |
1.632840E-01 |
|
|
